Ruxience 500 MG/50 ML vial 50ML
Ended Awarded Last action
- Contract number
- SPE2DR26FA0QH
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,940
Award facts
- Contract value 100% obligated
- $1,939.51 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $1,939.51 to AmerisourceBergen Drug Corp for Ruxience 500 mg/50 ml vials on December 15, 2025, with completion scheduled for December 16, 2025. This competitively awarded, firm fixed-price order represents a continuation of the company's substantial pharmaceutical supply relationship with DLA. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a major U.S. pharmaceutical distributor.
This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.999 billion prime contract vehicle running through December 2026 that provides comprehensive global pharmaceutical support to military healthcare programs. The IDC enables the company to supply a diverse range of pharmaceutical products, vaccines, medical devices, and specialized healthcare commodities to support the Defense Health Agency, U.S. Coast Guard, and other federal health systems. Ruxience, a biosimilar to rituximab used in oncology and immunology treatments, reflects the specialized nature of medical products AmerisourceBergen delivers through its federal contracts, which span therapeutic domains from specialty medications to generic drugs and medical supplies.
Quick answers
Who was awarded contract SPE2DR26FA0QH?
SPE2DR26FA0QH was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 15, 2025.
How much is contract SPE2DR26FA0QH worth?
The government has obligated $1,940 on SPE2DR26FA0QH.
Is contract SPE2DR26FA0QH an order under another contract?
Yes. SPE2DR26FA0QH is a delivery order under SPE2DR25D2100, an indefinite delivery contract.
Was contract SPE2DR26FA0QH competed?
The extent of competition for SPE2DR26FA0QH was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award